European Commission Recommends Regulatory Midway For COVID-19 Products
Executive Summary
The EU is addressing the regulatory obstacles that threaten to reduce the speed at which vital products needed to treat COVID-19 are produced.
You may also be interested in...
‘Months Of Activity’ Lost By Notified Bodies: New EU Measures May Be Needed
The European Commission has admitted that MDR implementation has been severely compromised by COVID-19, and potential delays in notified body conformity assessment of products must be addressed to avoid device shortages for patients.
Commission Provides Regulatory Advice For COVID-19 Medtech Sector Entrants Amid Counterfeit Concerns
A new European Commission guidance document explains the regulatory basics and emergency market entry criteria for new entrants to the devices sector amid the COVID-19 crisis.
The 11 EU Standards Freely Available In COVID-19 Fight And Where To Find Them
Manufacturers normally must pay to access medtech and personal protective equipment standards. But now some are freely available in the EU.